Bioequivalence and Bioavailability Forum 19:26 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Distribution to erythrocytes of Methylphenidate [Bioanalytics]

posted by EKY - Thailand, 2019-01-04 03:08  - Posting: # 19727
Views: 202

According to available data that methylphenidate and its metabolites are distributed between plasma (57%) and erythrocytes (43%) in blood.

In the bioanalysis for quantification of methylphenidate in plasma, there are some hemolysis samples.

Has anyone experienced that hemolysis samples (plasma) affect the bioanalysis or the reported plasma concentrations?

Can the respective plasma concentrations from hemolysis samples be fallacious?

Best Regards,

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,022 posts in 4,057 threads, 1,297 registered users;
online 10 (0 registered, 10 guests [including 8 identified bots]).

Like dreams, statistics are a form
of wish fulfillment.    Jean Baudrillard

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed